Innate immune cells play a crucial role in bone development and repair. Macrophages are the main effector cells in immune responses to implants and are indispensable for bone healing success. The heterogeneity and plasticity of macrophages make them a prime target for immune system modulation to enhance bone repair and regeneration. It is believed that the polarization of macrophage phenotype towards the anti-inflammatory M2, rather than the inflammatory M1 phenotype, promotes osteogenesis. Tissue-engineered bioimplants are potentially capable of producing signals to modulate macrophage polarization. Therefore, development of smart immunomodulatory bioimplants via manipulation of their properties seem a promising strategy for tuning immune responses to optimize bone repair without any unwanted inflammatory reactions. The purpose of the present review is to summarize the currently available studies performed on the effects of macrophage polarization, especially towards M2 phenotype, both in bone repair and in bioimplant-stimulated osteogenesis. Moreover, this literature highlights the need to focus future studies on the development of smart immunomodulatory implants capable of switching macrophage polarization-enhancing bone implant-host tissue integration.
INTRODUCTION
Immediately after the implantation of the tissueengineered bone substitute, macrophages as the primary effector cells are recruited into the implant carefully designed in order to escape unwanted immune response. 1 Biocompatibility is one of the properties of tissueengineered constructs. Traditionally, those constructs that were inert by the view of the elements of the host immune system were considered favorable. However, in the contemporary view, this approach does not suffice. The constructs need be immunomodulatory, to force the immune cells, in particular, macrophages, adapt an active positive role in bone repair. 2, 3 Macrophages are heterogeneous and plastic in nature in a sense that their phenotypes/polarizations span a wide spectrum from inflammatory M1 to antiinflammatory or pro-regenerative M2 cells. Microenvironmental signals within the injury or implant site modulate the polarization of macrophages, potentially letting regenerative processes to settle down. [4] [5] [6] [7] Despite the fact that macrophages are the first to rush into the injury site, and also remain in situ for long, they have not attracted enough attention of researchers to unveil their non-immune functions.
Miron and colleagues reported in a systemic review that only 10% of investigations in the area of orthopedic and dental implants have included immune cells behavior on implant surfaces. 8 It seems crucial, however, to revisit both the distinct and the integrative roles of different macrophage populations in bone repair.
In the present review, we attempt to summarized macrophage characterizations, modulation, and their interaction with implanted bone substitutes to shed light to the path of developing smart immunomodulatory bone implants, which may be the key advancement to benefit from the regenerative capacity of this powerful endogenous cell source.
Macrophages

Macrophages Origin and Function
Macrophages are differentiated immune cells. They are activated in response to diverse environmental signals and participate in different functions including phagocytosis of microbial and parasites pathogens, efferocytosis of apoptotic cells, presenting antigen cells to T lymphocytes, inflammation, vascularization, wound healing and immunomodulation. 
Macrophage Heterogeneity and Plasticity
Macrophages are a heterogeneous cell population and show a wide spectrum of polarization/phenotype from classically pro-inflammatory M1 until alternative anti-inflammatory M2 phenotype related to their functional diversity. 6, 21 Macrophage polarization into M1 pro-inflammatory or M2 anti-inflammatory/wound healing macrophages is very importance in bone regeneration and hence the significance of bone/biomaterial interfaces lies within their abilities to polarize macrophages either into M1 or M2 macrophages.
Pro-Inflammatory M1 Macrophages
The pro-inflammatory M1 phenotype is classically activated by injury, infection, bacterial products [lipopolysaccharide (LPS)] and cytokines such as tumor necrosis factor (TNF)-α and interferon (IFN)-γ. 22 They produce high levels of reactive oxygen species (ROS), nitric oxide (NO) and pro-inflammatory cytokines such as interleukin (IL)-1, IL-2, IL-6, IL-12, TNF-α and IFN-γ. 22 These cells are characterized by the production of anti-inflammatory cytokines such as IL-10, Chemokine (C-C motif) ligand (CCL)-18, and CCL-22 and low expression of IL-12.
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M2 macrophages may produce a number of osteogenic growth factors such as BMP-2, 29 TGF-β, 30 osteopontin, 31 1,25-dihydroxy-vitamin D3. 32 The growth factors code for extracellular matrix deposition and new bone formation and are classical features of the M2 macrophage.
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M2 macrophages, a non-uniform population, are further subdivided into M2a, M2b, M2c, and M2d categories based on signals activated, cell surface markers, and a wide spectrum of functions. Naïve macrophages can be switched into M2a phenotype by IL-4 and/or IL-13, and are involved in immune responses against parasites mediated by Th2 cells. M2a macrophages, also called wound-healing macrophages, are pro-fibrotic identified by high surface expression of IL-4R and FcεR, Dectin-1, CD163, CD206 and CD209. 33 Moreover, they express high levels of arginase-1 in response to IL-4 that depletes Larginine, thereby suppressing T cell responses and depriving iNOS of its substrate. Arginase-1 provides precursors for collagen and fibroblast stimulating factor, thus supporting their role in extracellular matrix sediment and wound closure. 24 Given the role of M2a macrophages in the remodeling of extracellular matrix and wound stabilization, however, they must be carefully investigated to prevent unfavorable fibrotic changes in an injured tissue or surrounding biomaterial implants.
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M2b macrophages are considered as an immuneregulating member of the M2 macrophage family and are instigated by IL-1R ligands, LPS, and immune complexes. In addition to IL-10, they produce IL-1, IL-6, and TNF-α.
2 M2c macrophages increase in number in presence of IL-10, TGF-β and glucocorticoids. This subgroup was defined as deactivated or antiinflammatory macrophages and is known to be involved in tissue repair, remodeling, and angiogenesis. 35 They produce anti-inflammatory cytokines such as IL-10 and TGF-β and express multiple receptors, such as CD163, CD206 and RAGE receptors. 36 The M2d macrophages, when activated by IL-6 and adenosines produce various cytokines including IL-10, TGF-β, and IL-12 as well as vascular endothelial growth factor (VEGF)-A. 37, 38 For further details, the following well-written review are suggested.
39
Macrophage Modulation
Non-Aided M2 Macrophage Polarization in Bone Healing
Bone healing is a complex four-stage process comprising of inflammation, soft callus formation, hard callus formation and bone remodeling stages. 40 Immediately after bone injury and following the orchestrated microenvironmental signals such as secretion of pro-inflammatory cytokines, macrophages infiltrate into injury site and initiate bone repair via triggering inflammatory cascade and secretion of both pro-inflammatory and regenerative cytokines. 41 Macrophage recruitment into the injury site is mediated by CC chemokine CCL-2 and its receptor, chemokine (C-C motif) receptor (CCR)-2. ). They concluded that pro-inflammatory cytokines are necessary for successful bone healing. 46 In addition to In the late inflammatory phase, when inflammatory cytokines subside and the levels of T-lymphocyte cytokines (e. g., IL-4, and IL-13) rise, M0 and M1 macrophages will gradually polarize towards M2 antiinflammatory/regenerative macrophages. M2 cytokine secretion profile IL-4, IL-13, IL-10, IL-1ra, Arginase 1 and chitotriosidase lead to a downregulation of the inflammatory responses and upregulation of regenerative pathways such as angiogenesis, extracellular matrix formation, and remodeling. [50] [51] [52] Potent bioactive growth factors for osteoblasts including BMP-2, 53 BMP-4 54 and Wnt family members 16 produced mainly by M2 macrophages are inducers of extracellular matrix deposition and new bone formation. 8 Guihard et al claimed 25 that bone formation was stimulated by M1-derived OSM in conditions of inflammation, infection and/or injury, not attributable to M2 macrophages, despite their known role in tissue repair. 55, 56 Wu et al created a bone injury model, osteonecrosis, by injection of methylprednisolone (corticosteroid medication) in mice. During the early stage of osteonecrosis, M1 inflammatory cells infiltrate into the necrotic zone and secrete high levels of TNF-α. However, in the late stage of osteonecrosis, the expression of TNF-α gradually decrease, followed by the appearance of a large M2 cell population in the necrotic area. The authors speculated that a high number of M2 macrophages could account for reduced inflammation, hence promoting tissue repair. Their claim was further supported and confirmed by the histologic findings of the new bone formation around the necrotic bone. 57 Considering the significance of M2 macrophages in bone regeneration in the late phase of injury, in the proceeding sections, we will discuss drugs, cytokines and biomaterial agents potentially capable of polarizing macrophages towards M2 macrophage phenotype.
Tissue
Engineering-Aided M2 Macrophage Polarization in Bone Healing
Modification of an implant surrounding milieu may potentially bring about macrophage polarization, where their functions will follow suite. To adopt such a strategy, one can look into signals stemming from three main components of any tissue engineered construct. Not only that, their respectful components may display a crucial role in macrophage modulation. What needs to keep our gaze into is the M1/M2 ratio, a critical dynamic index that oscillates temporally according to the necessities of any particular phase of the healing. Accordingly, any core constituents of the construct can chemically be targeted with the aim of making them immunomodulatively smart, bringing about the justneeded temporal variations in macrophage phenotypes and different landscapes of signaling molecules, all in favor of rapid and more natural healing of the wound. The following subsections are an attempt to cover the state of the art in this strategy.
Scaffold-Aided M2 Macrophage Polarization
Bone scaffolds are synthetic ECM made from different biomaterials such as biodegradable natural and synthetic polymers and ceramic using diverse fabrication techniques such as electrospinning and Freeze drying. [58] [59] [60] These 3D matrices should support osteogenic cell attachment, recruitment, growth, proliferation, and differentiation. In addition, they should induce or support vascularization. 61 Thus physical, chemical and mechanical scaffold's properties should be regulated carefully, 62 since Scaffold properties have a significant influence on host immune responses, they may raise detrimental or otherwise beneficial reactions that remarkably modify the healing process. In smart immunomodulative scaffolds, these properties should be manipulated in such an optimized manner that can switch macrophage polarization towards M2 phenotype. However, keeping the balance seems critical, for an excessive number of M2 macrophages may have the opposite effect in stimulating the immune system. 63 Physicochemical properties of scaffolds including geometry, topography, pore size, porosity, surface charge and hydrophobicity can influence implant-host interaction and hence alter the cell surface adherence and function. 2 Lee et al showed that chemical surface modification using divalent cations (Ca 2+ and Sr 2+ ) combined with the nanostructured Ti surface dramatically polarize J774 macrophages cell line into regenerative M2 macrophage phenotype. They concluded that surface bioactive ion modification may prove beneficial by reducing inflammatory condition. 64 Similarly, Chen et al demonstrated that macrophages in response to β-Tricalcium phosphate β-TCP extracts (i.e., one of the main combustion products of bone) were switched to M2 phenotype. The polarization led to the release of osteoinductive molecules and antiinflammatory cytokines, such as BMP2 that promoted the differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) into the osteoblast. 3 Magnesium ion (Mg 2+ ) is another divalent used in the fabrication of scaffolds, however, it evokes an excessive inflammatory response, restricting its efficacy in bone tissue engineering. 65 In dental implantology in vitro conditions, Barth et al, showed that high RAW 264.7 cell density (mouse macrophages cell line) on rough SLA (sandblasted and acid etched) implants were associated with the early bone formation. It was found that SLA promoted polarization of macrophages towards M2-like phenotype through upregulation of the macrophage attractant chemokines such as MCP-1and MIP-1a and concomitant downregulation of the secretion of the M1-typical chemokines such as IP-10. These findings indicate that early bone formation occurs more rapidly on the macrophage-rich SLA implants with M2 polarization promoting implant-induced healing and osseointegration. 67 For further details in regards to the role of scaffold's different biomaterials in macrophage modulation, the reader is recommended to read the review by Sridharan et al.
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Cell-Aided M2 Macrophage Polarization
In bone tissue engineering, a variety of primary and/or stem cells, either in 2D/3D forms, mono/cocultured, are introduced to the site of injury, where they themselves may demonstrate osteogenic activities or may recruit native cells to show osteogenic/angiogenic activities by the production of selective growth factors. Hoovering upon more recent investigations in the type of cells utilized, our understanding of the reciprocal role of macrophages in implants is superficial. Amongst few studied carried out, one encounters a possibility of either direct or indirect interaction between the implanted cells with host macrophages. Horwood and colleagues 68 and
Sridharan et al 39 have covered the relevant details in their reviews. MSCs play a central role in bone repair due to their osteogenic potential and capacity. Gong et al showed that coculture of MSC with macrophages polarizes macrophages towards M2 phenotype along with an increase in alkaline phosphatase (ALP), osteogenic markers and bone mineralization paralleled by a decrease in M-derived cytokines. 69 Another study showed that there is direct cell-to-cell interaction between macrophages and osteogenic cells. 70 Guihard et al reported that M1 inflammatory macrophages, and not M2 cells, produce OSM via prostaglandin (PG)-E2 and cyclooxygenase (COX)-2 pathway, 71 differentiating MSCs into osteoblasts. 25 Since there is not a general consensus among researchers in this area, further detailed studies are required to investigate the interaction between MSC-macrophage modulation during developmental osteogenesis and bone repair.
Signaling Molecules-Aided M2 Macrophage Polarization
Signaling molecules are an ensemble of cytokines, growth factors, peptides, nucleotides, and drugs that activate or inactivate specific signaling pathways, capable of osteogenic induction. Routes to up the level of the signaling molecules are diverse: injected directly into the site, released from implanted scaffolds, or even secreted from already seeded cells. Alvarez and colleagues 72 have reviewed the means of immunomodulative signaling molecules release from scaffolds in their more recent stunning review. Regardless of the mode of administration, the quantity of signaling molecules at the site of implant is to match the exact phase of the bone healing. Activation of M2 macrophages favors the osteogenesis by further releases of anti-inflammatory cytokines. On the contrary, over-activation of M1 macrophages would entail a rise in inflammatory cytokines, postponing the healing process. Therefore, a temporally adjusted balance in the ratio of M1/M2 is what is expected of smart immunomodulative constructs.
Schlundt et al induced the M2/Th2 phenotype through local administration of IL-4 and IL-13 in the fractured area in C57BL/6 mice leading to a higher bone formation in comparison to the untreated control group during the 3-week treatment period. 73 The results address the bone repair potentials of M2 macrophage polarization. In another study, Loi et al showed that pre-osteoblastic MC3T3 cells co-cultured with M1 macrophages increase ALP activity, osteocalcin concentration, and matrix mineralization. The osteogenesis by M1-MC3T3 co-cultures was further enhanced by macrophage phenotype modulation to M2 via IL-4 treatment 72 hours after seeding. The findings indicate that modulating M1 macrophages into the M2-like phenotype through IL-4 treatment can mimic the physiological shift from inflammation to tissue regeneration. 74 Furthermore, Silfversward et al showed that male mice depleted of Th2-associated antiinflammatory cytokines, including IL-4 and IL-13, had reduced cortical bone mass and strength, indicating that these cytokines are somehow involved in the modulation of bone regeneration. 75 However, the same researchers have recently shown that IL-4 and IL-13 depleted mice demonstrated no alterations in fracture healing or heterotopic bone formation, despite an earlier reduction in cortical bone mass in mice. In addition, they reported an altered expression of autonomous nerve… and markers of neovascularization in the same depleted mice. The authors suggested that the relatively weak effects of IL-4 and IL-13 in bone formation can be supported by other factors including insulin-like growth factor (IGF)-1, growth hormone (GH), transforming growth factor-β1 (TGF)-β1 and bone morphogenetic proteins (BMPs).
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In patients suffering from chronic arthritic disorders and other end-stage degenerative conditions, total joint replacement (TJR) is strongly indicated. However, wear particles from artificial joints appear in the same space as time goes by. Rao et al aimed to control the inflammatory reactions that occur in response to wear particles production, specifically polarization of M1 macrophages towards the M2 phenotype by IL-4. They reported that wear particles induce a pro-inflammatory process for osteolysis, may potentially be modulated into M2 macrophages, promoting tissue healing and angiogenesis rather than periprosthetic osteolysis and implant loosening. 45 Clodronate (brand name: Bonefos) is an antiosteoporotic drug approved for the prevention and treatment of osteoporosis in men and post-menopausal women to decrease complications of hyperparathyroidism, vertebral fractures, hypercalcemia due to underlying medical condition, multiple myeloma and fracture-related pain because of its potent anti-inflammatory and analgesic effects via a decrease in inflammatory cytokines such as IL-1β, IL-6, and TNF-α. 77 Cho et al showed that in clodronate liposome model, any depletion of mature phagocytic macrophages or M1 macrophage was associated with increased trabecular bone mass and increased parathyroid hormone-induced anabolism. Moreover, clodronate liposomes increased efferocytosis and gene expression associated with M2 macrophages as well as expression of genes associated with bone formation including Wnt3a, Wnt10b, and TGF-β1. 16 The results indicate that clodronate induces macrophage polarization towards M2 and osteogenesis through upregulation of Wnts and TGF-β1 production in bone.
Another study reported that clodronate-induced macrophage depletion does not disrupt early bone healing phase, but severely delayed hard callus formation. They observed that M2 macrophages were obviously predominant during the ossification phase and concluded that in order to meet a successful bone repair M1/M2 macrophage ratio should be wellbalanced.
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CONCLUSION
This review is meant to serve as a pillar for tissue engineering to advance basic and clinical studies with aims of modulating the microenvironment of injury site for optimal bone regeneration. Macrophages are heterogeneous and plastic in nature; the two main phenotypes are M1 and M2, the absolute number and the ratio of which vary in different stages of repair. Signals present in the environment trigger phenotype switching. Inflammatory M1 macrophages are those involved in the secretion of inflammatory factors prolonging the repair process. M2 macrophages, on the other hand, are those cells that hasten the healing process by releasing anti-inflammatory factors. 78 It is noteworthy that neither a reduction in the number of M1 macrophages nor an increase in M2 macrophages per se would favor the success of repair. Immunocompatibility refers to the overall attributes of the implant where the key players not only deactivate the foreign body reaction but also allow the implant to enjoy the integration with the host tissue via the immune system enhancement. Components of the scaffolds and their physicochemical properties, as well as types of the biomaterials utilized, cytokines and type of cells seeded, are the main factors encoding the immunomodulatory features of the smart implant. Therefore, in-depth acquisition of further evidence of key elements and their interplay, as well as an adequate and effective spatiotemporal macrophage phenotype switching, are what determine the outcome of the implant.
Future Prospective
There seems to be an intrinsic algorithm that runs the switching for and against different stages of the battle at the site of the implant. Any repair strategy that mimics best the subtending spatiotemporal interactions and hijacks the capabilities of the immune system in their own favor seem promising in rendering implants smart.
